CSF3R and atypical chronic myeloid leukemia, BCR-ABL1 negative: CSF3R T618I mutations were observed in 10WHO-defined CNL cases, at a mutational frequency of 83% (10/12), and were not seen inWHO-defined aCML, PMF (n=76), or CMML (n=94) cases.